IMMUTEP Ltd
IMMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001506184
No open-market purchases or sales by IMMUTEP Ltd insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $692.0K in total; no superinvestor holds it.
Other share classesPRRUF
13F holders, Q1 2023
Institutional positions in IMMUTEP Ltd as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −6 vs. Q4 2022
- Shares held
- 2.96M
- −1.18M (−28.5%) vs. Q4 2022
- Total value
- $4.95M
- −$2.30M (−31.7%) vs. Q4 2022
- New holders
- 2
- 7 more added
- Sold out
- 8
- 5 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMMP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $692.0K |
| Q1 2026 | 26 | $916.3K |
| Q4 2025 | 25 | $5.68M |
| Q3 2025 | 32 | $3.68M |
| Q2 2025 | 24 | $2.75M |
| Q1 2025 | 23 | $2.95M |
| Q4 2024 | 26 | $4.22M |
| Q3 2024 | 23 | $4.26M |
| Q2 2024 | 28 | $4.84M |
| Q1 2024 | 23 | $5.40M |
| Q4 2023 | 23 | $4.90M |
| Q3 2023 | 21 | $3.68M |
| Q2 2023 | 21 | $3.41M |
| Q1 2023 | 19 | $4.95M |
| Q4 2022 | 25 | $7.25M |
| Q3 2022 | 21 | $8.31M |
| Q2 2022 | 22 | $11.2M |
| Q1 2022 | 23 | $14.4M |
| Q4 2021 | 25 | $17.5M |
| Q3 2021 | 28 | $30.9M |
| Q2 2021 | 28 | $32.9M |
| Q1 2021 | 13 | $14.0M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding IMMUTEP Ltd; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Oracle Investment Management Inc | 1,350,802 | $2.27M | 2.24% | −91,523−6.3% | Reduced |
| Morgan Stanley | 616,760 | $1.04M | 0.00% | +100,634+19.5% | Added |
| Millennium Management LLC | 530,138 | $891.0K | 0.00% | −197,414−27.1% | Reduced |
| Susquehanna International Group, LLP | 159,330 | $267.7K | 0.00% | +8,241+5.5% | Added |
| Citadel Advisors LLC | 91,626 | $153.9K | 0.00% | +72,116+369.6% | Added |
| Dimensional Fund Advisors LP | 81,928 | $137.6K | 0.00% | +10,813+15.2% | Added |
| Verition Fund Management LLC | 35,000 | $58.8K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 18,722 | $31.5K | 0.00% | 00.0% | Unchanged |
| Old Mission Capital LLC | 16,441 | $27.6K | 0.00% | −4,717−22.3% | Reduced |
| XY Capital Ltd | 13,949 | $23.4K | 0.02% | +13,949 | New |
| Integrated Advisors Network LLC | 13,000 | $21.8K | 0.00% | 00.0% | Unchanged |
| Envestnet Asset Management Inc | 22,606 | $13.5K | 0.00% | −43,228−65.7% | Reduced |
| Bank of America Corp | 5,053 | $8.49K | 0.00% | +2,486+96.8% | Added |
| Belpointe Asset Management LLC | 3,000 | $5.04K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 2,748 | $4.62K | 0.00% | +1,322+92.7% | Added |
| BNP Paribas Arbitrage, SA | 2,100 | $3.53K | 0.00% | +1,400+200.0% | Added |
| Tower Research Capital LLC (TRC) | 105 | $0 | 0.00% | −7,296−98.6% | Reduced |
| Royal Bank of Canada | 16 | $0 | 0.00% | 00.0% | Unchanged |
| Hantz Financial Services, Inc. | 10 | $0 | 0.00% | +10 | New |
| Artal Group S.A. | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −21,785−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −11,926−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −2,514−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,353−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −58−100.0% | Sold out |